Skip to content
healthcare.dev

AVGEMSI

NDC 83831-123, Gemcitabine, injection, solution, from Avyxa Pharma, LLC.

Product NDC
83831-123
Status
Listed
Labeler
Avyxa Pharma, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219920
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83831-123 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GEMCITABINE HYDROCHLORIDE38 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
83831-123-01838310123011 VIAL, MULTI-DOSE in 1 CARTON (83831-123-01) / 26.3 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e11eeff7-bcaf-4bf1-8da8-88138e01af84
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83831-123

Use it

Look up 83831-123 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83831-123 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83831-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.